Had a quick look through, nothing overly positive/ negative stands out for me.
Disappointing to see sales aren't increasing at a faster rate, it's also interesting that they've made a note about patients cycling on/off different treatments. Was also hoping for some more positive news re PBS restrictions in Aus, and some clarification on the Aridol import restriction in the US. No doubt the questions will be asked in the call tomorrow.
